1-Bromo-2-methyl-4-nitrobenzene | CAS:7149-70-4

We serve 1-Bromo-2-methyl-4-nitrobenzene CAS:7149-70-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-Bromo-2-methyl-4-nitrobenzene

Chemical Name:1-Bromo-2-methyl-4-nitrobenzene
CAS.NO:7149-70-4
Synonyms:1-Bromo-2-methyl-4-nitrobenzene
2-Bromo-5-nitrotoluene
 
Physical and Chemical Properties:
Density 1.6±0.1 g/cm3
Boiling Point 278.0±20.0 °C at 760 mmHg
Melting Point 78-80 °C(lit.)
Molecular Formula C7H6BrNO2
Molecular Weight 216.032
Flash Point 121.9±21.8 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.593
 
Specification:
Appearance:Yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 1-Bromo-2-methyl-4-nitrobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-5-nitrotoluene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-5-nitrotoluene Use and application,2-Bromo-5-nitrotoluene technical grade,usp/ep/jp grade.


Related News: Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.2,4-Dibromopyridine manufacturer Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.Elaidic Acid supplier Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.1-Benzhydrylazetidin-3-One vendor Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.